LOS ANGELES--(BUSINESS WIRE)--Mayer B. Davidson, MD, Chief Medical Officer of Mellitus Health, Inc., will announce clinical data during poster and special poster presentations and a moderated poster discussion at the American Diabetes Association 78th Scientific Sessions in Orlando, FL.
Effect of Remote Glucose Monitoring Utilizing Computerized Insulin Dose
Adjustment Algorithms on A1C Levels—A Preliminary Report
|Special Poster Session|
|Saturday, June 23, 2018|
|11:30 AM to 12:30 PM|
|Moderated Poster Discussion|
|New Insights from Continuous Glucose Monitoring|
|Monday, June 25, 2018|
|12:00 PM to 1:00 PM|
|Exhibit Hall (ePoster Theater A)|
About Mellitus Health, Inc.
Mellitus Health automates algorithmic dosing of insulin, offering clinicians precision recommendations in seconds. Founded in 2014 as Insulin Algorithms by Mayer B. Davidson, MD, Josh Davidson and Michael Margolese, the Los Angeles firm rebranded in 2018 as Mellitus Health, Inc.
Unique in the market, its cloud-based insulin titration software works with all eight standard regimens, all types of insulins and all 125 insulin combinations, providing precision insulin dosing recommendations to clinicians in just seconds.
The FDA-cleared and CE-registered solution accepts readings from all major glucometer brands and integrates seamlessly into existing clinical workflows.
The software’s algorithms derive from 35 years of clinical research by Mayer B. Davidson, MD, a former president of the American Diabetes Association and author of Meeting the American Diabetes Association Standards of Care: An Algorithmic Approach to Clinical Care of the Diabetes Patient, first published by the American Diabetes Association in 2010 and now in its second edition, published in 2017 with co-author Stanley H. Hsia, MD.
Learn more at www.MellitusHealth.com.